Treatment Decisions in Patients With Potentially Nonsurvivable Burn Injury in Australia and New Zealand: A Registry-Based Study

被引:3
|
作者
Tracy, Lincoln M. [1 ]
Gold, Michelle [2 ]
Reeder, Sandra [1 ,3 ]
Cleland, Heather J. [4 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia
[2] Alfred Hlth, Palliat Care Serv, Melbourne, Vic, Australia
[3] Monash Partners Acad Hlth Sci Ctr, Clayton, Vic, Australia
[4] Alfred Hlth, Victorian Adult Burns Serv, Melbourne, Vic, Australia
来源
JOURNAL OF BURN CARE & RESEARCH | 2023年 / 44卷 / 03期
关键词
OF-LIFE CARE; DEATH; MORTALITY; END; EPIDEMIOLOGY; GUIDELINES; OUTCOMES; TRENDS;
D O I
10.1093/jbcr/irac017
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Whilst burn-related mortality is rare in high-income countries, there are unique features related to prognostication that make examination of decision-making practices important to explore. Compared to other kinds of trauma, burn patients (even those with nonsurvivable injuries) may be relatively stable after injury initially. Complications or patient comorbidity may make it clear later in the clinical trajectory that ongoing treatment is futile. Burn care clinicians are therefore required to make decisions regarding the withholding or withdrawal of treatment in patients with potentially nonsurvivable burn injury. There is yet to be a comprehensive investigation of treatment decision practices following burn injury in Australia and New Zealand. Data for patients admitted to specialist burn services between July 2009 and June 2020 were obtained from the Burns Registry of Australia and New Zealand. Patients were grouped according to treatment decision: palliative management, active treatment withdrawn, and active treatment until death. Predictors of treatment initiation and withholding or withdrawing treatment within 24 hours were assessed using multilevel mixed-effects logistic regression. Descriptive comparisons between treatment groups were made. Of the 32,186 patients meeting study inclusion criteria, 327 (1.0%) died prior to discharge. Fifty-six patients were treated initially with palliative intent and 227 patients had active treatment initiated and later withdrawn. Increasing age and burn size reduced the odds of having active treatment initiated. We demonstrate differences in demographic and injury severity characteristics as well as end of life decision-making timing between different treatment pathways pursued for patients who die in-hospital. Our next step into the decision-making process is to gain a greater understanding of the clinician's perspective (eg, through surveys and/or interviews).
引用
收藏
页码:675 / 684
页数:10
相关论文
共 50 条
  • [31] Outpatient presentations to burn centers: Data from the Burns Registry of Australia and New Zealand outpatient pilot project
    Gabbe, Belinda J.
    Watterson, Dina M.
    Singer, Yvonne
    Darton, Anne
    BURNS, 2015, 41 (03) : 446 - 453
  • [32] End-of-life anticancer treatment: A nationwide registry-based study
    Mattsson, Thea O.
    Pottegard, Anton
    Jorgensen, Trine L.
    Green, Anders
    Bliddal, Mette
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 33 - 33
  • [33] Treatment outcome of new smear positive pulmonary tuberculosis patients in Hamadan, Iran: A registry-based cross-sectional study
    Khazaei, Salman
    Hassanzadeh, Jafar
    Rezaeian, Shahab
    Ghaderi, Ebrahim
    Khazaei, Somayeh
    Hafshejani, Abdollah Mohammadian
    Salehiniya, Hamid
    Zahiri, Ali
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (04): : 825 - 830
  • [34] An investigation of early enteral nutrition provision in major burn patients in Australia and New Zealand
    Kurmis, Rochelle
    Nicholls, Caroline
    Singer, Yvonne
    Edgar, Dale W.
    Wood, Fiona M.
    Gabbe, Belinda J.
    Tracy, Lincoln M.
    NUTRITION & DIETETICS, 2022, 79 (05) : 582 - 589
  • [35] The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)
    Bose, Bhadran
    Milanzi, Elasma
    Pascoe, Elaine M.
    Johnson, David W.
    Badve, Sunil V.
    PLOS ONE, 2023, 18 (11):
  • [36] A retrospective review of sildenafil in the Australia and New Zealand Fontan registry: indications and treatment responses
    Rueter, Phidias
    O'Dell, Mathilde
    Celermajer, David
    O'Donnell, Clare
    Ayer, Julian
    d'Udeke, Yves
    Cordina, Rachael
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2024, 16
  • [37] Statins, risk of death and stroke in patients with dementia - a registry-based study
    Petek, B.
    Villa-Lopez, M.
    Winblad, B.
    Kramberger, M. G.
    Von Euler, M.
    Xu, H.
    Eriksdotter, M. E.
    Garcia-Ptacek, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 84 - 84
  • [38] Hypothyroidism among pediatric cancer patients:: A nationwide, registry-based study
    Madanat, Laura-Maria S.
    Laehteenmaeki, Paeivi M.
    Hurme, Saija
    Dyba, Tadeusz
    Salmi, Toivo T.
    Sankila, Risto
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (08) : 1868 - 1872
  • [39] Mortality in patients with behavioural and psychological symptoms of dementia: a registry-based study
    Bransvik, Vanja
    Granvik, Eva
    Minthon, Lennart
    Nordstrom, Peter
    Nagga, Katarina
    AGING & MENTAL HEALTH, 2021, 25 (06) : 1101 - 1109
  • [40] Prognosis in rheumatoid arthritis patients with COPD: A nationwide, registry-based study
    Hyldgaard, Charlotte
    Lokke, Anders
    Pedersen, Alma Becic
    Ulrichsen, Sinna Pilgaard
    Hilberg, Ole
    Bendstrup, Elisabeth
    Ellingsen, Torkell
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50